Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors
Phase 1
Recruiting
- Conditions
- Castrate Resistant Prostate CancerNUT CarcinomaChronic Myelomonocytic LeukemiaMyelofibrosis
- Interventions
- First Posted Date
- 2022-08-04
- Last Posted Date
- 2025-01-14
- Lead Sponsor
- Epigenetix, Inc.
- Target Recruit Count
- 50
- Registration Number
- NCT05488548
- Locations
- 🇺🇸
Mayo Clinic Arizona, Phoenix, Arizona, United States
🇺🇸Mayo Clinic Florida, Jacksonville, Florida, United States
🇺🇸Dana Farber Cancer Institute, Boston, Massachusetts, United States
News
No news found